Osimertinib Impurity 15 | CAS 2092773-15-2 - Request Quote
Osimertinib Impurity 15
| SZ CAT No: | SZ-O014038 |
| CAS No | 2092773-15-2 |
| Mol.F. | C7H7FN2O3 |
| Mol.Wt. | 186.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Osimertinib Impurity 15 is chemically 4-Fluoro-2-methoxy-6-nitroaniline. Osimertinib Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Osimertinib Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Osimertinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2092773-15-2
Purchase 2092773-15-2
Order 2092773-15-2
Enquire 2092773-15-2
price of 2092773-15-2
2092773-15-2 Supplier
2092773-15-2 Manufacturer
2092773-15-2 Exporter
buy high quality Osimertinib Impurity 15
Purchase Osimertinib Impurity 15
Osimertinib Impurity 15 suppliers
Osimertinib Impurity 15 manufacturers
Osimertinib Impurity 15 price
Order Osimertinib Impurity 15
Enquire Osimertinib Impurity 15
Osimertinib Impurity 15 cost
Osimertinib Impurity 15 Supplier
Osimertinib Impurity 15 Distributor
Osimertinib Impurity 15 for Method Validation
Osimertinib Reference Standard
Osimertinib Impurity 15 for ANDA Filing
Osimertinib Impurity 15 for Forced Degradation Studies
Osimertinib Impurity 15 Identification Standards
Osimertinib Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


